Retina Implant Lengthens Headstart In Subretinal Implant Market

By CE-marking the Alpha AMS second-generation subretinal implant, Retina Implant has further widened the gap between itself and its rivals who are also developing devices to restore vision in patients blinded by degenerative retinal diseases such as retinitis pigmentosa.

More from Archive

More from Medtech Insight